Hida, Tomoyuki <br/><br/>
Tumor Volume Analysis as a Predictive Marker for Prolonged Survival in Anaplastic Lymphoma Kinase-rearranged Advanced Non-Small Cell Lung Cancer Patients Treated With Crizotinib.  [electronic resource] 

 -  Journal of thoracic imaging  Mar 2020 
 - 101-107 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1536-0237 
<br/><br/><label>Standard No.: </label>10.1097/RTI.0000000000000413  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anaplastic Lymphoma Kinase--drug effects<br/>Antineoplastic Agents--therapeutic use<br/>Carcinoma, Non-Small-Cell Lung--diagnostic imaging<br/>Crizotinib--therapeutic use<br/>Female<br/>Humans<br/>Lung--diagnostic imaging<br/>Lung Neoplasms--diagnostic imaging<br/>Male<br/>Middle Aged<br/>Survival Analysis<br/>Tomography, X-Ray Computed<br/>Treatment Outcome<br/>Tumor Burden